BioSpace News Archive

Drug Development

Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100

The procedure of certification of quality and non-clinical data involves an assessment of the available data in view of future registration and the related European Scientific Data Requirements, not including any clinical data or benefit-risk assessment.

May 6, 2019
·
6 min read
Biotech Beach

Axonics® Announces ARTISAN-SNM Pivotal Study Results Presented at the American Urological Association Annual Meeting

ARTISAN-SNM study results were presented on May 5 at the 2019 American Urological Association (AUA) Annual Meeting in Chicago by Professor Howard Goldman, M.D., of the Cleveland Clinic.

May 6, 2019
·
5 min read
Drug Development

Shattuck Labs, Inc. Announces Initiation of Phase 1 Clinical Trial of SL-279252 (PD1/OX40L)

SL-279252 is the first Agonist Redirected Checkpoint molecule to enter clinical development from the Shattuck pipeline.

May 6, 2019
·
2 min read
Drug Development

Ligand Acquires Milestone and Royalty Rights to SB206 from Novan, Inc.

Phase 3 drug candidate targeting molluscum

May 6, 2019
·
7 min read
Business

Welltower Expands Leadership Team in Investments

Welltower Inc. (NYSE: WELL) today announced that Ayesha Menon and Edward Cheung have joined the Company as Senior Vice Presidents of Investments.

May 6, 2019
·
3 min read
Calliditas Therapeutics to Host Conference Call to Provide Business Update and 2019 Q1 Report

On May 8, 2019, at 07:00am CET, Calliditas Therapeutics (“Calliditas”) will publish its business update for the first quarter 2019.

May 6, 2019
·
2 min read
Business

TraceLink Achieves 44% Overall Revenue Growth for Q1 2019

Financial and company results for the first quarter of 2019

May 6, 2019
·
4 min read
Biotech Beach

Regulus Therapeutics Announces Restructuring of Term Loan

Term Loan Amended to Provide Up to Two Years of Interest Only Payments and Extension of Maturity Date to May 2022

May 6, 2019
·
4 min read
BioForest

Global CRISPR and CAS Gene Market to Surpass US$ 7,603.8 million by 2026

The global CRISPR and CAS gene Market was valued at US$ 1,388.1 million in 2017, and is projected to exhibit a CAGR of 20.8% during the forecast period (2018 – 2026).

May 6, 2019
·
3 min read
Policy

Delaware District Court Denies Hologic Motion for Injunction to Halt the Sale of Minerva Surgical Product

Last Thursday, May 2, 2019, the U.S District Court for the District of Delaware denied Hologic’s request for the Court to halt all sales of Minerva’s Endometrial Ablation product.

May 6, 2019
·
2 min read